SCHEMBL5111977

SCHEMBL5111977

CCOC1Oc2c(c(=O)oc3ccc(C)cc23)C1c1c(O)c2cc(C)ccc2oc1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 3/20 0.48
MAOB P27338 2/20 0.42
MAPT P10636 8/20 0.40
RXFP1 Q9HBX9 3/20 0.40
TP53 P04637 3/20 0.40
KDM4E B2RXH2 5/20 0.38
MEN1 O00255 4/20 0.38
CYP3A4 P08684 4/20 0.38
KMT2A Q03164 4/20 0.38
THRB P10828 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CSNK2A2 P19784 5/20 0.37
CSNK2B P67870 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5119698 0.90 PRNP (0.40) NQO1MAOBMAPTRXFP1KDM4E
SCHEMBL5115619 0.89 NQO1 (0.38) NQO1MAOBMAPTRXFP1TP53
SCHEMBL5125494 0.88 NQO1 (0.47) NQO1MAPTRXFP1TP53MEN1
SCHEMBL5115168 0.88 NQO1 (0.47) NQO1MAOBRXFP1TP53KDM4E
SCHEMBL5118330 0.88 CA12 (0.46) NQO1RXFP1CSNK2A2CSNK2BCSNK2A1
SCHEMBL5126126 0.88 NQO1 (0.48) NQO1MAOBMAPTRXFP1TP53
SCHEMBL5114980 0.87 NQO1 (0.52) NQO1MAOBMAPTTP53KDM4E
SCHEMBL5120322 0.87 NQO1 (0.46) NQO1KDM4EMEN1KMT2AHPGD
SCHEMBL5114210 0.83 ALDH1A1 (0.47) NQO1MAPTRXFP1TP53KDM4E
SCHEMBL5341518 0.82 NQO1 (0.51) NQO1MAOBMAPTRXFP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed
EP-1648902-A1 SUBSTITUTED FUROCHROMENES, PREPARATION THEREOF AND THEIR ANTIINFLAMMATORY ACTION PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) 2006-04-26 EP disclosed
WO-2005010007-A1 SUBSTITUTED FUROCHROMENES, PREPARATION THEREOF AND THEIR ANTIINFLAMMATORY ACTION PLIVA- ISTRAZIVACKI INSTITUT D.O.O. (HR) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action CYP11B2, CYP11B1, LTC4S NQO1 60/4885MAOB 322/4885MAPT 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.